KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 103 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,235,059 | +70.7% | 71,103 | +38.3% | 0.01% | +66.7% |
| Q2 2023 | $723,628 | -24.4% | 51,394 | -38.8% | 0.01% | -33.3% |
| Q3 2021 | $957,000 | +61.4% | 83,983 | +97.3% | 0.01% | +80.0% |
| Q2 2021 | $593,000 | -44.0% | 42,571 | -25.6% | 0.01% | -50.0% |
| Q1 2021 | $1,059,000 | +5.8% | 57,230 | +1.1% | 0.01% | -9.1% |
| Q4 2020 | $1,001,000 | +208.0% | 56,627 | +48.3% | 0.01% | +266.7% |
| Q3 2019 | $325,000 | -39.7% | 38,173 | -4.0% | 0.00% | -25.0% |
| Q2 2019 | $539,000 | -33.0% | 39,773 | -10.8% | 0.00% | -33.3% |
| Q1 2019 | $805,000 | -21.4% | 44,568 | +22.3% | 0.01% | -25.0% |
| Q4 2018 | $1,024,000 | +44.0% | 36,453 | +30.7% | 0.01% | +60.0% |
| Q3 2018 | $711,000 | +91.6% | 27,893 | +30.3% | 0.01% | +150.0% |
| Q2 2018 | $371,000 | – | 21,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |